| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹852.53 Cr |
| Fresh Issue | ₹400.00 Cr |
| Offer for Sale | ₹452.53 Cr |
| Face Value | โน2 Per Equity Share |
| Price Band | โน380.00-400.00 per share |
| BSE Code | 544421 |
| NSE Code | ELLEN |
| Registrar | Kfin Technologies Ltd. |
| Lead Managers | JM Financial Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 37 shares and in multiples thereof
Incorporated in 1973, Ellenbarrie Industrial Gases Limited (EIGL) is an Indian company specialising in the production and supply of industrial, medical, and speciality gases. The company provides essential gases such as oxygen, carbon dioxide, acetylene, nitrogen, helium, hydrogen, argon, and nitrous oxide. EIGL also offers dry ice, synthetic air, fire-fighting gases, medical oxygen, liquefied petroleum gas (LPG), welding mixtures, and specialty gases, serving a wide range of industries.
Services: EIGL offers project engineering services, leveraging technical expertise to design, install, and commission tonnage air separation units (ASUs) on a turnkey basis. The company also provides medical gas pipeline solutions, assisting healthcare facilities with installing, operating, and maintaining their systems. Additionally, EIGL supplies medical equipment such as anesthesia workstations, ventilators, spirometers, sterilizers, bedside monitors, and lung diffusion testing machines.
EIGL serves various customers, classified into three categories:
Industries Served
EIGL caters to several industries, including:
Operations & Workforce
Employees: As of March 31, 2025, EIGL employed 281 permanent and 85 contractual employees.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (โน Cr.) |
|---|---|---|
| 1 | Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by the Company. | 210.00 |
| 2 | Setting up of an air separation unit at the Uluberia-II plant with a capacity of 220 TPD. | 104.50 |
| 3 | General Corporate Purposes | 55.95 |
| 4 | Issue Expenses | 59.87 |
| Total | 430.32 |
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 845.97 | 672.54 | 551.27 |
| Total Income | 348.43 | 290.20 | 223.71 |
| Profit After Tax | 83.29 | 45.29 | 28.14 |
| EBITDA | 109.74 | 61.53 | 33.59 |
| NET Worth | 333.62 | 250.15 | 203.32 |
| Reserves and Surplus | 467.17 | 403.35 | 356.51 |
| Total Borrowing | 245.30 | 176.90 | 101.10 |
| Amount in ₹ Crore | |||
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 16.88% |
| ROCE | 13.71% |
| Debt / Equity | 0.32% |
| RoNW | 24.97% |
| PAT Margin | 23.90% |
| EBITDA Margin | 35.12% |
| Price to Book Value | 20.93 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 6.36 | 5.91 |
| P/E (x) | 62.88 | 67.69 |
| Promoter Holding | 96.47% | 81.59% |
| Market Cap | โน5637.42 Cr. | |